Pear Therapeutics

Nancy M. Schlichting

Ms. Schlichting has served as a member of Pear’s board of directors since January 2021 and is chair of the Compensation Committee. From June 2003 until January 2017, Ms. Schlichting served as the chief executive officer of the Henry Ford Health System, where she helped lead a $4.7 billion integrated healthcare system. Ms. Schlichting has also served on the board of directors of Walgreens Boots Alliance, Inc (NASDAQ: WBA) since 2006 and chairs its Compensation and Leadership Development Committee. Ms. Schlichting has also served on the board of directors of the Duke University Health System since 2016, Encompass Health since 2018, and Hill-Rom Holdings, Inc since 2017, where she also serves as the chairperson of the Compensation and Management Development Committee. Ms. Schlichting also serves as a trustee for a number of organizations, including The Kresge Foundation since 2003 and Duke University since 2018. In addition, Ms. Schlichting has served as a director and vice chair of the Detroit Symphony Orchestra since 2016. Ms. Schlichting earned her BA from Duke University and her MBA from Cornell University in healthcare administration and accounting.

Back